Hybrid coronary revascularization: An overview of options for anticoagulation and platelet inhibition

Heart Surgery Forum

Volumn 13, Issue 6, 2010, Pages

  Zimrin, David ^a   Bonatti, Johannes ^a   Vesely, Mark R ^a   Lehr, Eric J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANIVAMERSEN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CANGRELOR; CLOPIDOGREL; ELINOGREL; HEPARIN; HIRULOG; PEGNIVACOGIN; PRASUGREL; PROTAMINE; TICAGRELOR; TICLOPIDINE; UNCLASSIFIED DRUG;

ANTICOAGULATION; BLEEDING; CONFERENCE PAPER; CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; DRUG SAFETY; HEART MUSCLE REVASCULARIZATION; HUMAN; HYBRID CORONARY REVASCULARIZATION; LOADING DRUG DOSE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT OUTCOME;

ANTICOAGULANTS; COMBINED MODALITY THERAPY; CORONARY ARTERY BYPASS; HUMANS; MYOCARDIAL REVASCULARIZATION; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE;

EID: 78650596434     PISSN: 10983511     EISSN: 15226662     Source Type: Journal    
DOI: 10.1532/HSF98.20101157     Document Type: Conference Paper

References (18)

1. Bonaros N, Schachner T, Wiedemann D, et al. 2009. Quality of life improvement after robotically assisted coronary artery bypass grafting. Cardiology 114:59-66.
2. Bonatti J, Lehr E, Vesely MR, Friedrich G, Bonaros N, Zimrin D. 2010. Hybrid coronary revascularization: which patients? When? How? Curr Opin Cardiol 25:568-74.
3. Byrne JG, Leacche M, Vaughan DE, Zhao DX. 2008. Hybrid cardiovascular procedures. JACC Cardiovasc Interv 1:459-68.
4. Cohen MG, Purdy DA, Rossi JS, et al. 2010. First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary intervention. Circulation 122:614-22.
5. Dyke CM, Smedira NG, Koster A, et al. 2006. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study. J Thorac Cardiovasc Surg 131:533-9.
6. Ferraris VA, Ferraris SP, Moliterno DJ, et al. 2005. The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary). Ann Thorac Surg 79:1454-61.
7. Harrington RA, Stone GW, McNulty S, et al. 2009. Platelet inhibition with cangrelor in patients undergoing PCI. N Eng J Med 361:2318-29.
8. Hirsh J, Anand SS, Halperin JL, Fuster V. 2001. Mechanism of action and pharmacology of unfractionated heparin. Arterioscler Thromb Vasc Biol 21:1094-6.
9. Kiaii B, McClure RS, Stewart P, et al. 2008. Simultaneous integrated coronary artery revascularization with long-term angiographic followup. J Thorac Cardiovasc Surg 136:702-8.
10. Kon ZN, Brown EN, Tran R, et al. 2008. Simultaneous hybrid coronary revascularization reduces postoperative morbidity compared with results from conventional off-pump coronary artery bypass. J Thorac Cardiovasc Surg 135:367-75.
11. Leon MB, Baim DS, Popma JJ, et al. 1998. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 339:1665-71.
12. Leonardi S, Rao SV, Harrington RA, et al. 2010. Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y(12)-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Effi cacy in nonurgent Percutaneous Coronary Interventions patients (INNOVATE-PCI). Am Heart J 160:65-72.
13. Poston R, Gu J, Manchio J, et al. 2005. Platelet function tests predict bleeding and thrombotic events after off-pump coronary bypass grafting. Eur J Cardiothorac Surg 27:584-91. (Pubitemid 40409728)
14. Reicher B, Poston RS, Mehra MR, et al. 2008. Simultaneous "hybrid" percutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes. Am Heart J 155:661-7.
15. Smedira NG, Dyke CM, Koster A, et al. 2006. Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: the results of the EVOLUTION-OFF study. J Thorac Cardiovasc Surg 131:686-92.
16. Vivas D, Angiolillo DJ. 2010. Platelet P2Y12 receptor inhibition: an update on clinical drug development. Am J Cardiovasc Drugs 10:217-26.
17. Wiviott SD, Antman EM, Braunwald E. 2010. Prasugrel. Circulation 122:394-403.
18. Zhao DX, Leacche M, Balaguer JM, et al. 2009. Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room. J Am Coll Cardiol 53:232-41.